A new survey of physicians from global management consulting firm indicated that doctors believe the pharmaceutical industry could play a vital role in helping value based healthcare providers, such as accountable care organizations to deliver better care at lower cost.
Pharmas are currently lacking in this area. The survey had 200 respondents who currently make at least 25 percent of their income through value-based care arrangements.
In order to help pharmas need to solving the payer’s problem and focus on population disease costs. The pharmas should work with payers and providers to refine guidelines for using a particular drug so it provides maximum benefit.
Sixty one percent of respondents said they strongly agreed that there is a role for branded drug therapies in reducing the overall cost of patient care when used appropriately. Thirty seven percent agreed that pharmaceutical companies have the capabilities to reduce the total cost of care and improve patient outcomes.
Doctors’ lack of confidence in pharma companies. For years they have gone to payers and providers with data on how their drugs compare to the standard of care. They haven’t given their customers what they wanted, true evidence on how their drugs optimize total disease costs.
In today’s world of value-based care, there needs to be cooperation: As electronic records improve, payers, providers, and pharma are all discovering that each has data that the others need. They are going to have to learn to work together effectively.